Fevara PLC
23 July 2026
23 July 2026
Fevara plc
("Fevara", the "Company", or the "Group")
Result of Annual General Meeting 2026 - Update Statement
Fevara plc (LSE: FVA), the international specialist in livestock supplements, provides the following update in accordance with Provision 4 of the UK Corporate Governance Code in respect of the shareholder vote against at the Company's Annual General Meeting ("AGM") held on 11 February 2026.
As announced on 12 February 2026, all resolutions were duly passed at the AGM. However, the Board noted that Resolution 6, regarding the re-election of Gillian Watson as a Non-Executive Director, received 39.26% of votes against.
Following the AGM, the Company undertook engagement with a limited number of shareholders, including certain shareholders who voted against the resolution, to understand the reasons for the dissent. Despite limited response from the shareholders approached, the Board believes that the principal concern related to Ms Watson's being unable to attend two late scheduled Board meetings during the financial year. The Board believes that, while the absences are always regrettable, they do not give rise to any concerns regarding Ms Watson's overall commitment or effectiveness, and that she continues to make a valuable contribution to the Board.
The Board remains committed to maintaining an open and constructive dialogue with shareholders and will continue to engage, where appropriate, on governance matters. Further disclosure will be provided in the Company's next Annual Report.
Enquiries:
|
Fevara plc |
+44 (0) 1228 554 600 |
|
Canaccord Genuity Limited (Corporate Broker) Max Hartley / Harry Rees
|
+44 (0)20 7523 8000 |
|
Hudson Sandler (PR Adviser) Wendy Baker / Nick Moore |
+44 (0) 20 7796 4133 |
About Fevara plc:
Fevara is an international specialist in livestock supplements.
Fevara's purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture. The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including Crystalyx®, HorsLic®, Horslyx®, Scotmin Nutrition®, SmartLic® and Tracesure® Advanced.
Headquartered in Carlisle, Cumbria, in the UK, Fevara has five manufacturing sites in the UK, US and Brazil with three operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.
Fevara has been listed on the London Stock Exchange since 1972.
For more information, visit: www.fevara.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.